Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.

Published in: Pharmacoepidemiology and drug safety (2022)

Among new users of a systemic treatment for AD, dupilumab was most used treatment by far.

Keyphrases